Search

everythinglearnresearchcommunity

for

Search:↓

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

Hepatitis C virus can cause skin diseases and dermatologists play a crucial role in identifying these conditions.

Regulatory T cells help prevent autoimmunity and have potential for treating autoimmune diseases.

Alopecia areata involves specific immune cells, offering potential treatment targets.

Treating H. pylori infection might help cure alopecia areata.

Methotrexate effectively treated a 2-year-old's generalized pustular psoriasis without side effects.

Catalytic antibodies are early indicators and active participants in the development of systemic lupus erythematosus.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Genetic discoveries are leading to new treatments for alopecia areata.

Optical coherent tomography can effectively detect steroid use by analyzing hair changes.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

A mother and son both had ulcerative colitis and alopecia, suggesting a genetic link in autoimmune disorders and successful treatment with cyclosporine.

The review concludes that accurate diagnosis of different types of hair loss requires proper biopsy techniques and understanding the hair growth cycle and underlying causes.

Hair transplants can lead to hair loss from lichen planopilaris, and patients should be tested and wait two years before the procedure.

People with Down syndrome are more likely to have alopecia areata and need regular skin check-ups.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.

People with alopecia areata have fewer regulatory T-cells than those with other skin conditions.

People with Lichen planopilaris are more likely to have certain autoimmune and endocrine disorders but less likely to have conditions like allergies and diabetes.

Squaric acid dibutylester effectively treats alopecia areata.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Detailed patient history and physical exams are crucial for diagnosing hair loss.

The conclusion is that understanding and addressing the psychological effects of alopecia areata is important for effective treatment.

The four main causes of hair loss in children are fungal infections, pulling out hair, autoimmune hair loss, and stress-related hair shedding.

Glucocorticoid treatment improved symptoms in a girl with Satoyoshi disease.

Abrocitinib may effectively treat stubborn alopecia universalis.

People with Lichen Planopilaris are more likely to have autoimmune diseases, especially Systemic Lupus Erythematosus, and less likely to have diabetes and some other common conditions.

There is no cure for alopecia areata, and treatment success depends on the individual's situation.